Table 1 Clinical characteristics of NPC patients with either low or high LHX2 expression.
From: LHX2 facilitates the progression of nasopharyngeal carcinoma via activation of the FGF1/FGFR axis
Characteristics | No. of patients | Expression of LHX2 | P value | |
|---|---|---|---|---|
Low, n (%) | High, n (%) | |||
Age | ||||
≤45 | 35 | 13 (30.2) | 22 (62.9) | 0.317 |
>45 | 63 | 30 (47.6) | 33 (52.3) | |
Sex | ||||
Male | 74 | 34 (45.9) | 40 (54.1) | 0.469 |
Female | 24 | 9 (37.5) | 15 (62.5) | |
T stage | ||||
T1–T2 | 47 | 1 (55.3) | 21 (44.7) | 0.028 |
T3–T4 | 51 | 17 (33.3) | 34 (66.7) | |
N stage | ||||
N0 | 28 | 12 (66.7) | 6 (33.3) | 0.031 |
N1–N3 | 70 | 31 (38.7) | 49 (61.3) | |
TNM stage | ||||
III–IV | 84 | 33 (39.3) | 51 (60.7) | 0.025 |
I–II | 14 | 10 (71.4) | 4 (28.6) | |
Distant metastasis | ||||
Yes | 6 | 1 (16.7) | 5 (83.3) | 0.166 |
No | 92 | 42 (45.7) | 50 (54.3) | |
Death | ||||
Yes | 29 | 4 (13.8) | 25 (82.6) | 0.000 |
No | 69 | 39 (56.5) | 30 (43.5) | |
